US Patent Issued on April 21 for "Method of converting mitragynine to 7-hydroxymitragynine" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,560, issued on April 21. "Method of converting mitragynine to 7-hydroxymitragynine" was invented by Haywood Max Mitchell (Santa Barbara, C... Read More

US Patent Issued to QURIENT, LEAD DISCOVERY CENTER on April 21 for "Substituted pyrazolo[1,5-a[1,3,5triazines as CDK inhibitors" (South Korean, German Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,561, issued on April 21, was assigned to QURIENT Co. LTD. (Gyeonggi-do, South Korea) and LEAD DISCOVERY CENTER GMBH (Dortmund, Germany). "... Read More

US Patent Issued to CHIESI FARMACEUTICI on April 21 for "Pyridopyrimidines derivatives as P2X3 inhibitors" (Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,562, issued on April 21, was assigned to CHIESI FARMACEUTICI S.P.A. (Parma, Italy). "Pyridopyrimidines derivatives as P2X3 inhibitors" was... Read More

US Patent Issued to LG CHEM on April 21 for "Organic light-emitting device" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,563, issued on April 21, was assigned to LG CHEM Ltd. (Seoul, South Korea). "Organic light-emitting device" was invented by Dong Uk Heo (D... Read More

US Patent Issued to ILDONG PHARMACEUTICAL on April 21 for "Adenosine receptor antagonist compounds" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,564, issued on April 21, was assigned to ILDONG PHARMACEUTICAL Co. LTD. (Seoul, South Korea). "Adenosine receptor antagonist compounds" wa... Read More

US Patent Issued to PYRAMID BIOSCIENCES on April 21 for "Methods for preparing tyrosine receptor kinase inhibitors" (Indian, American Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,565, issued on April 21, was assigned to PYRAMID BIOSCIENCES INC. (Waltham, Mass.). "Methods for preparing tyrosine receptor kinase inhibi... Read More

US Patent Issued to SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES, ZHEJIANG HUAHAI PHARMACEUTICAL on April 21 for "Substituted cyclopenta[4,5pyrrolo[1,2-apyrazines as bruton's tyrosine kinase inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,566, issued on April 21, was assigned to SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES Co. LTD. (Shanghai) and ZHEJIANG HUAHAI PHARMACEUTICAL Co... Read More

US Patent Issued to Recurium IP Holdings on April 21 for "Salts and forms of a WEE1 inhibitor" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,567, issued on April 21, was assigned to Recurium IP Holdings LLC (San Diego). "Salts and forms of a WEE1 inhibitor" was invented by Chad ... Read More

US Patent Issued to Kymera Therapeutics on April 21 for "SMARCA degraders and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,568, issued on April 21, was assigned to Kymera Therapeutics Inc. (Watertown, Mass.). "SMARCA degraders and uses thereof" was invented by ... Read More

US Patent Issued to Biotelliga Holdings on April 21 for "Alkaloid-containing compositions and uses thereof" (New Zealander Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,569, issued on April 21, was assigned to Biotelliga Holdings Ltd. (Auckland, New Zealand). "Alkaloid-containing compositions and uses ther... Read More

• ««
• «
• 13166
• 13167
• 13168
• 13169
• 13170
• 13171
• 13172
• 13173
• 13174
• 13175
• »
• »»